David M. Taylor, PhD, MRPharmS
- 7Articles
- 17KReads1
- 2003–2009Active
- 16Collaborators
- 44Citations2
About
David M. Taylor, PhD, MRPharmS, has published extensively on the clinical use and cost analysis of antipsychotic medications, including risperidone and clozapine, in the treatment of schizophrenia and schizoaffective disorders. His work also addresses bipolar disorder, dementia, neurology, and patient care, with additional focus on complementary and alternative medicine such as St. John's Wort. Between 2003 and 2009, Taylor contributed seven articles to Psychiatrist.com, often collaborating with co-authors including Anna Sparshatt and Carol Paton.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
